Cargando…

Efficacy of docetaxel combined carboplatin for the treatment of patients with castration-resistant prostate cancer: A protocol of systematic review and meta-analysis

BACKGROUND: A numerous published studies have reported that docetaxel combined carboplatin (DC) has been utilized for the treatment of patients with castration-resistant prostate cancer (CRPC). However, there are still contradictory results. Therefore, this systematic review and meta-analysis will e...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Chun-Lin, Li, Jiu-Zhi, Fan, Wen-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249847/
https://www.ncbi.nlm.nih.gov/pubmed/32481312
http://dx.doi.org/10.1097/MD.0000000000020297